Previous studies reported that niclosamide inhibits TNF-α-induced NF-κB-dependent activity, increases ROS levels in AML cells, and enhances the sensitivity of lung cancer cells to ROS12,13. The gene discussed is NFKB1; the disease is acute myeloid leukemia.